AB Science announces Canadian patent for masitinib to treat ALS
Masitinib has received orphan drug designation from the US Food and Drug Administration.
Company News
EC approves Briumvi to treat relapsing forms of multiple sclerosis
Anavex Life Sciences receives US patent for ANAVEX 2-73 (blarcamesine)
Swiss company Lonza acquires Synaffix to boost ADC offering
Rentschler Biopharma and Ikarovec partner to expedite new gene therapies
China’s NMPA approves Vascepa for hypertriglyceridemia
InDex Pharmaceuticals signs licence deal with Viatris for cobitolimod
Algernon announces acceptance of Repirinast patent application in Japan
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
